skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8102

Vascular Health and Risk Management

(2,748,388) Views

Editor in Chief Professor Roland Asmar

1178-2048


Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial
Jean-Jacques Mourad, Viet Nguyen, Marilucy Lopez-Sublet, Bernard Waeber
Vascular Health and Risk Management 2007, 3:173-180
18 May 2007


Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials
Ramzi EL Féghali, Sophie Nisse-Durgeat, Roland Asmar
Vascular Health and Risk Management 2007, 3:165-171
18 May 2007


Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2
Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, Karen A Grace
Vascular Health and Risk Management 2007, 3:159-164
18 May 2007


A review of sitaxsentan sodium in patients with pulmonary arterial hypertension
Aaron B Waxman

Vascular Health and Risk Management 2007, 3:151-157
18 May 2007


Overweight, physical activity and high blood pressure in children: a review of the literature
Brian Torrance, K Ashlee McGuire, Richard Lewanczuk, Jonathan McGavock

Vascular Health and Risk Management 2007, 3:139-149
18 May 2007


Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy
Christoph Schindler, Peter Bramlage, Wilhelm Kirch, Carlos M Ferrario
Vascular Health and Risk Management 2007, 3:125-137
18 May 2007


Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis
Peter J Little, Mandy L. Ballinger, Narin Osman

Vascular Health and Risk Management 2007, 3:117-124
18 May 2007


Management of atrial fibrillation
Puneet Kakar, Christopher J Boos, Gregory YH Lip

Vascular Health and Risk Management 2007, 3:109-116
18 May 2007


Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
Jutta Dierkes, Claus Luley, Sabine Westphal

Vascular Health and Risk Management 2007, 3:99-108
18 May 2007


A review of picotamide in the reduction of cardiovascular events in diabetic patients
Andrea Celestini, Francesco Violi

Vascular Health and Risk Management 2007, 3:93-98
18 May 2007


Inhaled human insulin (Exubera®): clinical profile and patient considerations
Anthony H Barnett, Sri Bellary
Vascular Health and Risk Management 2007, 3:83-91
18 May 2007


Trandolapril/verapamil combination in hypertensive diabetic patients
José A García Donaire, Luis M Ruilope
Vascular Health and Risk Management 2007, 3:77-82
18 May 2007


Foot ulcers in the diabetic patient, prevention and treatment
Stephanie C Wu, Vickie R Driver, James S Wrobel, David G Armstrong
Vascular Health and Risk Management 2007, 3:65-76
18 May 2007


Cardiometabolic aspects of polycystic ovarian syndrome
Li Wei Cho, Harpal S Randeva, Stephen L Atkin

Vascular Health and Risk Management 2007, 3:55-63
18 May 2007


What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of: “All that is necessary for the triumph of evil is that good men do nothing?”
Chris R Triggle, David J Triggle
Vascular Health and Risk Management 2007, 3:39-53
18 May 2007


Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-Pedersen

Vascular Health and Risk Management 2007, 3:31-37
18 May 2007


Moexipril and left ventricular hypertrophy
George S Chrysant, PK Nguyen

Vascular Health and Risk Management 2007, 3:23-30
18 May 2007


A review of pulmonary arterial hypertension: role of ambrisentan
Robyn J Barst

Vascular Health and Risk Management 2007, 3:11-22
18 May 2007


Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors,  or both? Expectations from The ONTARGET  Trial Programme
Luis Miguel  Ruilope, Josep Redón, Roland Schmieder
Vascular Health and Risk Management 2007, 3:1-9
18 May 2007

  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University